ImportRefusal LogoImportRefusal

ELANCO US INC

⚠️ High Risk

FEI: 3012761605 • Indianapolis, IN • UNITED STATES

FEI

FEI Number

3012761605

📍

Location

Indianapolis, IN

🇺🇸
🏢

Address

450 Elanco Circle, , Indianapolis, IN, United States

High Risk

FDA Import Risk Assessment

53.5
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

2
Total Refusals
4
Unique Violations
11/10/2025
Latest Refusal
9/18/2025
Earliest Refusal

Score Breakdown

Violation Severity
67.5×40%
Refusal Volume
17.7×30%
Recency
96.2×20%
Frequency
20.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

1181×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

32801×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

721×

NEW VET DR

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the Federal Food, Drug, and Cosmetic Act in that it appears to be a new animal drug that is unsafe within the meaning of Section 512(a) of the Federal Food, Drug, and Cosmetic Act as it is not the subject of an approved new animal drug application, conditionally approved new animal drug application, or index listing, and no investigational new animal drug exemption applies.

751×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
11/10/2025
61PDA74TIRZEPATIDE (ANTI-DIABETIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/18/2025
60ZLY01AFOXOLANER (ANTIPARASITIC)
118NOT LISTED
3280FRNMFGREG
72NEW VET DR
Division of West Coast Imports (DWCI)

Frequently Asked Questions

What is ELANCO US INC's FDA import refusal history?

ELANCO US INC (FEI: 3012761605) has 2 FDA import refusal record(s) in our database, spanning from 9/18/2025 to 11/10/2025.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. ELANCO US INC's FEI number is 3012761605.

What types of violations has ELANCO US INC received?

ELANCO US INC has been cited for 4 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about ELANCO US INC come from?

All FDA import refusal data for ELANCO US INC is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.